Suppression of immune response by antigen-modified liposomes encapsulating model agents: A novel strategy for the treatment of allergy

Journal of Controlled Release

Volumn 167, Issue 3, 2013, Pages 284-289

  Ichikawa, Kanae ^a   Asai, Tomohiro ^a   Shimizu, Kosuke ^a   Yonezawa, Sei ^a   Urakami, Takeo ^a   Miyauchi, Haruna ^a   Kawashima, Hiroto ^a   Ishida, Tatsuhiro ^b   Kiwada, Hiroshi ^b   Oku, Naoto ^a  

^a UNIVERSITY OF SHIZUOKA   (Japan)

^b UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

Allergy; B cells; Liposome; Ovalbumin; Reverse targeting; Spleen

Indexed keywords

B CELLS; IMMUNE RESPONSE; INTRAVENOUS INJECTIONS; NOVEL STRATEGIES; OVALBUMINS; PRODUCTION OF; REVERSE TARGETING; SPLEEN;

ALLERGIES; CELLS; CYTOLOGY; DRUG DOSAGE; LIPOSOMES; MAMMALS;

ANTIGENS;

ALUMINUM POTASSIUM SULFATE; DOXORUBICIN; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; LIPOSOME; OVALBUMIN; OVALBUMIN MODIFIED LIPOSOME; UNCLASSIFIED DRUG;

ALLERGY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG FORMULATION; ENCAPSULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; IMMUNOMODULATION; IMMUNOSUPPRESSIVE TREATMENT; LOW DRUG DOSE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; ANTIGENS; CHOLESTEROL; DOXORUBICIN; FEMALE; HYPERSENSITIVITY; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; KIDNEY; LIPOSOMES; LIVER; LUNG; MICE; MICE, INBRED BALB C; MYOCARDIUM; OVALBUMIN; PHOSPHATIDYLCHOLINES; PHOSPHATIDYLETHANOLAMINES; POLYETHYLENE GLYCOLS; SPLEEN;

EID: 84874944145     PISSN: 01683659     EISSN: 18734995     Source Type: Journal    
DOI: 10.1016/j.jconrel.2013.02.002     Document Type: Article

References (23)

1. D. Papahadjopoulos, and A. Gabizon Liposomes designed to avoid the reticuloendothelial system Prog. Clin. Biol. Res. 343 1990 85 93
2. T.M. Allen, and A. Chonn Large unilamellar liposomes with low uptake into the reticuloendothelial system FEBS Lett. 223 1987 42 46
3. A.L. Klibanov, K. Maruyama, V.P. Torchilin, and L. Huang Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes FEBS Lett. 268 1990 235 237
4. D.D. Lasic, F.J. Martin, A. Gabizon, S.K. Huang, and D. Papahadjopoulos Sterically stabilized liposomes: a hypothesis on the molecular origin of the extended circulation times Biochim. Biophys. Acta 1070 1991 187 192
5. N. Oku, and Y. Namba Glucuronate-modified, long-circulating liposomes for the delivery of anticancer agents Methods Enzymol. 391 2005 145 162
6. D. Papahadjopoulos, T.M. Allen, A. Gabizon, E. Mayhew, K. Matthay, S.K. Huang, K.D. Lee, M.C. Woodle, D.D. Lasic, C. Redemann, and F.J. Martin Sterically stabilized liposomes: improvements in pharmacokinetics and antitumor therapeutic efficacy Proc. Natl. Acad. Sci. U. S. A. 88 1991 11460 11464
7. N. Oku, K. Doi, Y. Namba, and S. Okada Therapeutic effect of adriamycin encapsulated in long-circulating liposomes on Meth-A-sarcoma-bearing mice Int. J. Cancer 58 1994 415 419
8. H. Takahama, T. Minamino, H. Asanuma, M. Fujita, T. Asai, M. Wakeno, H. Sasaki, H. Kikuchi, K. Hashimoto, N. Oku, M. Asakura, J. Kim, S. Takashima, K. Komamura, M. Sugimachi, N. Mochizuki, and M. Kitakaze Prolonged targeting of ischemic/reperfused myocardium by liposomal adenosine augments cardioprotection in rats J. Am. Coll. Cardiol. 53 2009 709 717
9. N. Oku, T. Asai, K. Watanabe, K. Kuromi, M. Nagatsuka, K. Kurohane, H. Kikkawa, K. Ogino, M. Tanaka, D. Ishikawa, H. Tsukada, M. Momose, J. Nakayama, and T. Taki Anti-neovascular therapy using novel peptides homing to angiogenic vessels Oncogene 21 2002 2662 2669
10. T. Asai, and N. Oku Angiogenic vessel-targeting DDS by liposomalized oligopeptides Methods Mol. Biol. 605 2010 335 347
11. K. Atobe, T. Ishida, E. Ishida, K. Hashimoto, H. Kobayashi, J. Yasuda, T. Aoki, K. Obata, H. Kikuchi, H. Akita, T. Asai, H. Harashima, N. Oku, and H. Kiwada In vitro efficacy of a sterically stabilized immunoliposomes targeted to membrane type 1 matrix metalloproteinase (MT1-MMP) Biol. Pharm. Bull. 30 2007 972 978
12. Y. Murase, T. Asai, Y. Katanasaka, T. Sugiyama, K. Shimizu, N. Maeda, and N. Oku A novel DDS strategy, "dual-targeting", and its application for antineovascular therapy Cancer Lett. 287 2010 165 171
13. K. Ichikawa, T. Urakami, S. Yonezawa, H. Miyauchi, K. Shimizu, T. Asai, and N. Oku Enhanced desensitization efficacy by liposomal conjugation of a specific antigen Int. J. Pharm. 336 2007 391 395
14. B. Slutter, S.M. Bal, Z. Ding, W. Jiskoot, and J.A. Bouwstra Adjuvant effect of cationic liposomes and CpG depends on administration route J. Control. Release 154 2011 123 130
15. N. Yanasarn, B.R. Sloat, and Z. Cui Negatively charged liposomes show potent adjuvant activity when simply admixed with protein antigens Mol. Pharm. 8 2011 1174 1185
16. A. Kawakita, H. Shirasaki, M. Yasutomi, S. Tokuriki, M. Mayumi, H. Naiki, and Y. Ohshima Immunotherapy with oligomannose-coated liposomes ameliorates allergic symptoms in a murine food allergy model Allergy 67 2012 371 379
17. S. Naito, M. Taneichi, H. Kato, Y. Tanaka, Y. Ami, Y. Suzaki, M. Mori, Y. Nakano, H. Yamamura, K. Morokuma, K. Ohkuma, H. Miyake, M. Kiniwa, K. Komuro, and T. Uchida Selective inhibition of systemic anti-OVA IgE production in response to oral pre-treatment with OVA-liposome conjugates Int. Arch. Allergy Immunol. 129 2002 314 319
18. T. Yoshikawa, T. Uchida, S. Naito, A. Horino, M. Taneichi, H. Kato, K. Komuro, Y. Nakano, M. Mori, S. Nishinohara, J. Chiba, T. Kurata, and S. Tamura Suppression of specific IgE antibody responses by liposome-conjugated ovalbumin in mice sensitized with ovalbumin via the respiratory tract Int. Arch. Allergy Immunol. 121 2000 108 115
19. S. Naito, A. Horino, M. Nakayama, Y. Nakano, T. Nagai, J. Mizuguchi, K. Komuro, and T. Uchida Ovalbumin-liposome conjugate induces IgG but not IgE antibody production Int. Arch. Allergy Immunol. 109 1996 223 228
20. M. Henriksen-Lacey, K.S. Korsholm, P. Andersen, Y. Perrie, and D. Christensen Liposomal vaccine delivery systems Expert Opin. Drug Deliv. 8 2011 505 519
21. X. Wang, T. Ishida, and H. Kiwada Anti-PEG IgM elicited by injection of liposomes is involved in the enhanced blood clearance of a subsequent dose of PEGylated liposomes J. Control. Release 119 2007 236 244
22. H.A. Saitoh, K. Maeda, and M. Yamakawa In situ observation of germinal center cell apoptosis during a secondary immune response J. Clin. Exp. Hematop. 46 2006 73 82
23. G. Cinamon, M.A. Zachariah, O.M. Lam, F.W. Foss Jr., and J.G. Cyster Follicular shuttling of marginal zone B cells facilitates antigen transport Nat. Immunol. 9 2008 54 62